Groupe la Francaise’s Avidity Biosciences RNAM Stock Holding History

Groupe la Francaise’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-162,398	Closed	-$11.7M	–	512
2025 Q4	$11.7M	Buy	+162,398	New	+$10.5M	0.16%	87

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Groupe la Francaise's RNAM Position: Q1 2026 in Review

Groupe la Francaise sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 162,398 shares — an estimated $11.7M sold.

Groupe la Francaise first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $11.7M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Groupe la Francaise reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Groupe la Francaise sold 162,398 Avidity Biosciences shares in Q1 2026, an estimated $11.7M.
Groupe la Francaise first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Groupe la Francaise's Avidity Biosciences position peaked at $11.7M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Groupe la Francaise's 13F filing for Q1 2026, filed 21 May 2026.